Molecular Diagnostics – New tools for evidence-based medicine
Download the report (PDF)
The medical diagnostic (Dx) sector is playing a central role in the shifting health care and drug discovery landscape. Energized by the demand for changes in health care and driven by a wave of molecular advances, the Dx sector is responding with innovative new tools and technologies.
This report highlights some of the developments fueling this industry — accomplishments and promise as well as the challenges facing the sector.
